Preclinical /Experimental Pharmacology

Neuropharmacology

1. • Evaluation of neuroprotective effects of natural compounds in animal models of Alzheimer’s or Parkinson’s disease.

   • Study of nootropic (memory-enhancing) activity of herbal extracts.

   • Role of gut–brain axis modulation in depression and anxiety.

Cardiovascular Pharmacology

1. • Effect of novel agents on experimentally induced myocardial infarction.

   • Pharmacological evaluation of antihypertensive potential of phytochemicals.

   • Study on drugs targeting endothelial dysfunction and oxidative stress.

Cancer Pharmacology

1. • Anti-tumor efficacy of plant-derived bioactive molecules.

   • Combination therapy studies: phytochemicals with standard chemotherapeutics.

   • In vitro and in vivo evaluation of autophagy modulators in cancer.

Metabolic Disorders

1. • Experimental evaluation of antidiabetic activity of new molecules.

   • Role of natural products in obesity and metabolic syndrome.

   • Pharmacological intervention in non-alcoholic fatty liver disease (NAFLD).

In silico / Computational Pharmacology

• Molecular docking and simulation studies to identify drug–target interactions for neurodegenerative disorders.

• ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) profiling of lead phytoconstituents.

• Network pharmacology approaches for traditional medicines in multitarget diseases.

• Artificial intelligence (AI)-based prediction of adverse drug reactions.

Clinical / Translational Pharmacology

• Pharmacovigilance: Analysis of adverse drug reaction (ADR) patterns in hospital settings.

• Drug utilization evaluation (DUE) of antibiotics, antihypertensives, or antidiabetics.

• Pharmacogenomics: Study of genetic polymorphisms in drug-metabolizing enzymes (like CYP450) and their impact on therapy.

• Impact of patient counseling and pharmacist intervention on medication adherence.

Herbal / Natural Product Pharmacology

• Standardization and pharmacological evaluation of polyherbal formulations.

• Comparative study of synthetic vs. natural antioxidants in oxidative stress models.

• Role of adaptogens (e.g., Ashwagandha, Rhodiola) in stress-induced disorders.